SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the availability of the NovaSeq S4 flow cell, reagent kit and NovaSeq Xp workflow for its NovaSeq™ 6000 System. Flow cell ...
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output ...
Join our webinar where we will highlight key features of the NovaSeq™ X series including technology innovations, product updates, and features of the on-board DRAGEN™ secondary analysis. We will cover ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
New data on NovaSeq X Plus and workflow insights on Illumina Complete Long Reads unveiled at AGBT HOLLYWOOD, Fla., Feb. 8, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ilmn ), a global leader in DNA ...
Chennai: In order to perform genome sequencing more efficiently and cost-effectively, diagnostics solutions provider LifeCell announced the addition of ‘NovaSeq 6000’ sequencing system to their ...
Ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, kicking off this weekend, Illumina has announced a new molecular residual disease (MRD) product. The distributed ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The NovaSeq X Series is Illumina's most powerful sequencing system, delivering an unprecedented combination of high throughput and accuracy, and featuring streamlined informatics, breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results